These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9308078)

  • 1. Estimation of foetal brain dose from I-131 in the foetal thyroid.
    O'Hare NJ; Gilligan P; Murphy D; Malone JF
    Phys Med Biol; 1997 Sep; 42(9):1717-26. PubMed ID: 9308078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approximate distribution of dose among foetal organs for radioiodine uptake via placenta transfer.
    Millard RK; Saunders M; Palmer AM; Preece AW
    Phys Med Biol; 2001 Nov; 46(11):2773-83. PubMed ID: 11720346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a phantom to determine foetal organ doses from 131I in the foetal thyroid.
    O'Hare N; Murphy D; Malone JF
    Phys Med Biol; 2000 Sep; 45(9):2583-91. PubMed ID: 11008958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of radioiodine for embryo and fetus.
    Berkovski V; Eckerman KF; Phipps AW; Nosske D
    Radiat Prot Dosimetry; 2003; 105(1-4):265-8. PubMed ID: 14526968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a 9-months pregnant hybrid phantom and its internal dosimetry for thyroid agents.
    Hoseinian-Azghadi E; Rafat-Motavalli L; Miri-Hakimabad H
    J Radiat Res; 2014 Jul; 55(4):730-47. PubMed ID: 24515254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of fetal thyroid dose following iodine-131 administration during early stages of pregnancy in patients suffering from benign thyroid disorders.
    Pauwels EK; Thomson WH; Blokland JA; Schmidt ME; Bourguignon M; El-Maghraby TA; Broerse JJ; Harding LK
    Eur J Nucl Med; 1999 Nov; 26(11):1453-7. PubMed ID: 10552087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strontium biokinetic model for the pregnant woman and fetus: application to Techa River studies.
    Shagina NB; Fell TP; Tolstykh EI; Harrison JD; Degteva MO
    J Radiol Prot; 2015 Sep; 35(3):659-76. PubMed ID: 26295413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of CT dose to the fetus and pregnant female patient using patient-specific computational models.
    Xie T; Poletti PA; Platon A; Becker CD; Zaidi H
    Eur Radiol; 2018 Mar; 28(3):1054-1065. PubMed ID: 28887589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal and maternal dose assessment for diagnostic scans during pregnancy.
    Motavalli LR; Hakimabad HM; Azghadi EH
    Phys Med Biol; 2016 May; 61(9):3596-608. PubMed ID: 27065182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of inadvertent radioiodine treatment of Graves' disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing?
    Berg G; Jacobsson L; Nyström E; Gleisner KS; Tennvall J
    Acta Oncol; 2008; 47(1):145-9. PubMed ID: 17851865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-based comparison of maternal and foetal organ doses from (99m)Tc pertechnetate, DMSA, DTPA, HDP, MAA and MAG(3) diagnostic intakes during pregnancy.
    Saunders M; Palmer M; Preece A; Millard R
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1365-73. PubMed ID: 12271420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetus dose estimation in thyroid cancer post-surgical radioiodine therapy.
    Mianji FA; Diba JK; Babakhani A
    Radiat Prot Dosimetry; 2015 Jan; 163(1):27-36. PubMed ID: 24723189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulations of radioiodine exposure and protective thyroid blocking in a new biokinetic model of the mother-fetus unit at different pregnancy ages.
    Rump A; Hermann C; Lamkowski A; Abend M; Port M
    Arch Toxicol; 2022 Nov; 96(11):2947-2965. PubMed ID: 35922584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAR in the mother and foetus for RF plane wave irradiation.
    Dimbylow P
    Phys Med Biol; 2007 Jul; 52(13):3791-802. PubMed ID: 17664577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluence to absorbed foetal dose conversion coefficients for photons in 50 keV-10 GeV calculated using RPI-P models.
    Taranenko V; Xu XG
    Radiat Prot Dosimetry; 2008; 131(2):159-66. PubMed ID: 18519553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine treatment of hyperthyroidism in a pregnant women.
    Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG
    J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 129I in bovine thyroid from Gomel, Belarus, in 1990.
    Khrouch VT; Gavrilin YI; Brauer FP; Van Middlesworth L
    Health Phys; 1995 Jun; 68(6):860. PubMed ID: 7759270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modern views on the physiopathology of the foetal thyroid].
    Croce C; Giordano G
    Arch Sci Med (Torino); 1972; 129(4):243-51. PubMed ID: 17340697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncertainties in dose coefficients from ingestion of 131I, 137Cs, and 90Sr.
    Apostoaei AI; Miller LF
    Health Phys; 2004 May; 86(5):460-82. PubMed ID: 15083142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of the maternal and fetal thyroid from radioactive contamination by the administration of stable iodide during pregnancy. An experimental evaluation in chimpanzees.
    Noteboom JL; Hummel WA; Broerse JJ; de Vijlder JJ; Vulsma T; Jansen JT; van Bekkum DW
    Radiat Res; 1997 Jun; 147(6):691-7. PubMed ID: 9189167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.